Network meta-analysis (NMA) allows the combination of direct and indirect evidence from a set of randomized clinical trials. Performing NMA using individual patient data (IPD) is considered as a "gold standard" approach as it provides several advantages over NMA based on aggregate data. For example, it allows to perform advanced modelling of covariates or covariate-treatment interactions. An important issue in IPD NMA is the selection of influential parameters among terms that account for inconsistency, covariates, covariate-by-treatment interactions or non-proportionality of treatments effect for time to event data. This issue has not been deeply studied in the literature yet and in particular not for time-to-event data. A major difficulty...
Abstract Background This study aimed at applying the restricted mean survival time difference (rmstD...
Objectives: Network meta-analysis (NMA) methods extend the standard pair-wise framework to allow sim...
Background: Stratified medicine seeks to identify patients most likely to respond to treatment. Indi...
Introduction Individual patient data (IPD) present particular advantages in network meta-analysis (N...
Network meta-analysis (NMA) combines direct and indirect evidence from trials to calculate and rank...
The use of individual patient data (IPD) in network meta-analysis (NMA) is becoming increasingly pop...
Background: An Individual Patient Data (IPD) meta-analysis is often considered the gold-standard for...
Background: An Individual Patient Data (IPD) meta-analysis is often considered the gold-standard fo...
Network meta‐analysis (NMA) combines direct and indirect evidence from trials to calculate and rank ...
International audienceIn a meta-analysis combining survival data from different clinical trials, an ...
Background: An Individual Patient Data (IPD) meta-analysis is often considered the gold-standard for...
Network meta-analysis (NMA) combines direct and indirect evidence from trials to calculate and rank ...
Abstract Background This study aimed at applying the restricted mean survival time difference (rmstD...
Objectives: Network meta-analysis (NMA) methods extend the standard pair-wise framework to allow sim...
Background: Stratified medicine seeks to identify patients most likely to respond to treatment. Indi...
Introduction Individual patient data (IPD) present particular advantages in network meta-analysis (N...
Network meta-analysis (NMA) combines direct and indirect evidence from trials to calculate and rank...
The use of individual patient data (IPD) in network meta-analysis (NMA) is becoming increasingly pop...
Background: An Individual Patient Data (IPD) meta-analysis is often considered the gold-standard for...
Background: An Individual Patient Data (IPD) meta-analysis is often considered the gold-standard fo...
Network meta‐analysis (NMA) combines direct and indirect evidence from trials to calculate and rank ...
International audienceIn a meta-analysis combining survival data from different clinical trials, an ...
Background: An Individual Patient Data (IPD) meta-analysis is often considered the gold-standard for...
Network meta-analysis (NMA) combines direct and indirect evidence from trials to calculate and rank ...
Abstract Background This study aimed at applying the restricted mean survival time difference (rmstD...
Objectives: Network meta-analysis (NMA) methods extend the standard pair-wise framework to allow sim...
Background: Stratified medicine seeks to identify patients most likely to respond to treatment. Indi...